The authors regret that there has been an error published within Fig. 5 of this article. The authors inadvertently pasted the anti-spike plots for the "≥70 years" group instead of the pseudo-neutralising antibody plots (pages 808–809) to Fig. 5A and B. These plots replicate the "≥70 years" group in Fig. 4A and B on pages 806–807. The authors have confirmed that the error does not affect the interpretation of the results and the rest of the paper, and the plots for the "<70 years" group in Fig. 5 are correct. The revised Fig. 5 contains the correct plots for pseudo-neutralising antibody data has now been updated in the original publication. The authors would like to apologise for any inconvenience caused.
Corrigendum to “Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial” [J Infect 84(6) (2022) 795–813, 5511]
Xinxue Liu
Alasdair PS Munro
Shuo Feng
Leila Janani
Parvinder K Aley
Gavin Babbage
Marcin Bula
Katrina Cathie
Krishna Chatterjee
Wanwisa Dejnirattisai
Kate Dodd
Ehsaan Qureshi
Anna L Goodman
Christopher A Green
Linda Harndahl
John Haughney
Alexander Hicks
Agatha A van der Klaauw
Jonathan Kwok
Vincenzo Libri
Martin J Llewelyn
Alastair C McGregor
Angela M Minassian
Yama F Mujadidi
Kyra Holliday
Orod Osanlou
Daniel R Owens
Mihaela Pacurar
Adrian Palfreeman
Daniel Pan
Tommy Rampling
Karen Regan
Stephen Saich
Teona Serafimova
Dinesh Saralaya
Gavin R Screaton
Sunil Sharma
Ray Sheridan
Ann Sturdy
Piyada Supasa
Emma C Thomson
Shirley Todd
Chris Twelves
Robert C Read
Teresa Lambe
Jonathan S Nguyen-Van-Tam
Victoria Cornelius
Matthew D Snape
Saul N Faust
Corresponding author at: NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Issue date 2023 May.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.